{"doc_id": "PMID-8816450.txt", "sent_id": "S1", "tokens": ["Analysis", "of", "the", "ligand", "-", "binding", "domain", "of", "human", "retinoic", "acid", "receptor", "alpha", "by", "site", "-", "directed", "mutagenesis", "."], "sentence": "Analysis of the ligand - binding domain of human retinoic acid receptor alpha by site - directed mutagenesis .", "event_mentions": [{"id": "E1", "event_type": "Binding", "trigger": {"text": "binding", "start": 5, "end": 5}, "arguments": [{"entity_id": "T1", "text": "human retinoic acid receptor alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T1", "text": "human retinoic acid receptor alpha", "entity_type": "Protein", "start": 8, "end": 12}, {"id": "T10", "text": "binding", "entity_type": "Binding", "start": 5, "end": 5}]}
{"doc_id": "PMID-8816450.txt", "sent_id": "S2", "tokens": ["Three", "subtypes", "of", "retinoic", "acid", "receptors", "(", "RAR", ")", ",", "termed", "RAR", "alpha", ",", "RAR", "beta", ",", "and", "RAR", "gamma", ",", "have", "been", "described", "."], "sentence": "Three subtypes of retinoic acid receptors ( RAR ) , termed RAR alpha , RAR beta , and RAR gamma , have been described .", "event_mentions": [], "entity_mentions": [{"id": "T2", "text": "RAR alpha", "entity_type": "Protein", "start": 11, "end": 12}, {"id": "T3", "text": "RAR beta", "entity_type": "Protein", "start": 14, "end": 15}, {"id": "T4", "text": "RAR gamma", "entity_type": "Protein", "start": 18, "end": 19}]}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["They", "are", "composed", "of", "different", "structural", "domains", ",", "including", "distinct", "domains", "for", "DNA", "and", "ligand", "binding", "."], "sentence": "They are composed of different structural domains , including distinct domains for DNA and ligand binding .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["RARs", "specifically", "bind", "all-trans-retinoic", "acid", "(", "RA", ")", ",", "9-cis-RA", ",", "and", "retinoid", "analogs", "."], "sentence": "RARs specifically bind all-trans-retinoic acid ( RA ) , 9-cis-RA , and retinoid analogs .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "S5", "tokens": ["In", "this", "study", ",", "we", "examined", "the", "functional", "role", "of", "cysteine", "and", "arginine", "residues", "in", "the", "ligand", "-", "binding", "domain", "of", "hRAR", "alpha", "(", "hRAR", "alpha", "-", "LBD", ",", "amino", "acids", "154", "to", "462", ")", "."], "sentence": "In this study , we examined the functional role of cysteine and arginine residues in the ligand - binding domain of hRAR alpha ( hRAR alpha - LBD , amino acids 154 to 462 ) .", "event_mentions": [], "entity_mentions": [{"id": "T5", "text": "hRAR alpha", "entity_type": "Protein", "start": 21, "end": 22}, {"id": "T6", "text": "hRAR alpha", "entity_type": "Protein", "start": 24, "end": 25}]}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["All", "conserved", "cysteine", "and", "arginine", "residues", "in", "this", "domain", "were", "mutated", "by", "site", "-", "directed", "mutagenesis", ",", "and", "the", "mutant", "proteins", "were", "characterized", "by", "blocking", "reactions", ",", "ligand", "-", "binding", "experiments", ",", "transactivation", "assays", ",", "and", "protease", "mapping", "."], "sentence": "All conserved cysteine and arginine residues in this domain were mutated by site - directed mutagenesis , and the mutant proteins were characterized by blocking reactions , ligand - binding experiments , transactivation assays , and protease mapping .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "S7", "tokens": ["Changes", "of", "any", "cysteine", "residue", "of", "the", "hRAR", "alpha", "-", "LBD", "had", "no", "significant", "influence", "on", "the", "binding", "of", "all-trans", "RA", "or", "9-cis", "RA", "."], "sentence": "Changes of any cysteine residue of the hRAR alpha - LBD had no significant influence on the binding of all-trans RA or 9-cis RA .", "event_mentions": [], "entity_mentions": [{"id": "T7", "text": "hRAR alpha", "entity_type": "Protein", "start": 7, "end": 8}]}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["Interestingly", ",", "residue", "C-235", "is", "specifically", "important", "in", "antagonist", "binding", "."], "sentence": "Interestingly , residue C-235 is specifically important in antagonist binding .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["With", "respect", "to", "arginine", "residues", ",", "only", "the", "two", "single", "mutations", "of", "R-276", "and", "R-394", "to", "alanine", "showed", "a", "dramatic", "decrease", "of", "agonist", "and", "antagonist", "binding", "whereas", "the", "R272A", "mutation", "showed", "only", "a", "slight", "effect", "."], "sentence": "With respect to arginine residues , only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed only a slight effect .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["For", "all", "other", "arginine", "mutations", ",", "no", "differences", "in", "affinity", "were", "detectable", "."], "sentence": "For all other arginine mutations , no differences in affinity were detectable .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "", "tokens": ["The", "two", "mutations", "R217A", "and", "R294A", "caused", "an", "increased", "binding", "efficiency", "for", "antagonists", "but", "no", "change", "in", "agonist", "binding", "."], "sentence": "The two mutations R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist binding .", "event_mentions": [], "entity_mentions": []}
{"doc_id": "PMID-8816450.txt", "sent_id": "S12", "tokens": ["From", "these", "results", ",", "we", "can", "conclude", "that", "electrostatic", "interactions", "of", "retinoids", "with", "the", "RAR", "alpha", "-", "LBD", "play", "a", "significant", "role", "in", "ligand", "binding", "."], "sentence": "From these results , we can conclude that electrostatic interactions of retinoids with the RAR alpha - LBD play a significant role in ligand binding .", "event_mentions": [{"id": "E2", "event_type": "Positive_regulation", "trigger": {"text": "significant role", "start": 20, "end": 21}, "arguments": [{"entity_id": "T12", "text": "binding", "role": "Theme"}]}, {"id": "E3", "event_type": "Binding", "trigger": {"text": "binding", "start": 24, "end": 24}, "arguments": [{"entity_id": "T8", "text": "RAR alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T8", "text": "RAR alpha", "entity_type": "Protein", "start": 14, "end": 15}, {"id": "T11", "text": "significant role", "entity_type": "Positive_regulation", "start": 20, "end": 21}, {"id": "T12", "text": "binding", "entity_type": "Binding", "start": 24, "end": 24}]}
{"doc_id": "PMID-8816450.txt", "sent_id": "S13", "tokens": ["In", "addition", ",", "antagonists", "show", "distinctly", "different", "requirements", "for", "efficient", "binding", ",", "which", "may", "contribute", "to", "their", "interference", "in", "the", "ligand", "-", "inducible", "transactivation", "function", "of", "RAR", "alpha", "."], "sentence": "In addition , antagonists show distinctly different requirements for efficient binding , which may contribute to their interference in the ligand - inducible transactivation function of RAR alpha .", "event_mentions": [{"id": "E4", "event_type": "Negative_regulation", "trigger": {"text": "interference", "start": 17, "end": 17}, "arguments": [{"entity_id": "T14", "text": "transactivation", "role": "Theme"}]}, {"id": "E5", "event_type": "Positive_regulation", "trigger": {"text": "transactivation", "start": 23, "end": 23}, "arguments": [{"entity_id": "T9", "text": "RAR alpha", "role": "Theme"}]}], "entity_mentions": [{"id": "T9", "text": "RAR alpha", "entity_type": "Protein", "start": 26, "end": 27}, {"id": "T13", "text": "interference", "entity_type": "Negative_regulation", "start": 17, "end": 17}, {"id": "T14", "text": "transactivation", "entity_type": "Positive_regulation", "start": 23, "end": 23}]}
